• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗马II型模块化问卷日语版及肠易激综合征严重程度指数的验证

Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index.

作者信息

Shinozaki Masae, Kanazawa Motoyori, Sagami Yasuhiro, Endo Yuka, Hongo Michio, Drossman Douglas A, Whitehead William E, Fukudo Shin

机构信息

Department of Behavioral Medicine, Tohoku University Graduate School of Medicine, Seiryo, Aoba, Sendai, Japan.

出版信息

J Gastroenterol. 2006 May;41(5):491-4. doi: 10.1007/s00535-006-1799-9.

DOI:10.1007/s00535-006-1799-9
PMID:16799892
Abstract

BACKGROUND

Instruments for measuring the presence and severity of specific irritable bowel syndrome (IBS) symptoms, comparable to those used in Western countries, have been lacking in Japan. The aim of this study was to develop, validate, and confirm the reliability of the Japanese version of the Rome II modular questionnaire for IBS (RIIMQ-J) and the IBS severity index (IBSSI-J).

METHODS

Forty-nine patients in the university hospital with chronic or recurrent abdominal pain and discomfort and/or altered bowel habits were enrolled. With Rome II criteria, 27 patients were diagnosed as having IBS, and the other 22 patients were evaluated as having other functional bowel disorders (FBDs). The English versions of RIIMQ and IBSSI were translated into Japanese. After back-translation and approval of the questionnaire, subjects completed both questionnaires twice within 14 days.

RESULTS

Cronbach's alpha of the RIIMQ-J was high (0.72). The sensitivity of RIIMQ-J for the diagnosis of IBS was also high (89%). The specificity of RIIMQ-J for denial of IBS among patients with other FBD was satisfactory (73%). The IBSSI-J showed high internal consistency (0.69) and reproducibility (intraclass correlation coefficient, 0.86, P < 0.001).

CONCLUSIONS

The RIIMQ-J and IBSSI-J are valid, reliable, and appropriate instruments for detecting and assessing the severity of IBS status in Japanese patients.

摘要

背景

在日本,一直缺乏与西方国家所使用的类似的、用于测量特定肠易激综合征(IBS)症状的存在情况及严重程度的工具。本研究的目的是开发、验证并确认IBS的罗马II型模块化问卷日文版(RIIMQ-J)和IBS严重程度指数(IBSSI-J)的可靠性。

方法

招募了49名在大学医院患有慢性或复发性腹痛、不适和/或排便习惯改变的患者。根据罗马II标准,27名患者被诊断为患有IBS,另外22名患者被评估为患有其他功能性肠病(FBD)。将RIIMQ和IBSSI的英文版翻译成日文。在回译并批准问卷后,受试者在14天内两次完成这两份问卷。

结果

RIIMQ-J的Cronbach's alpha值较高(0.72)。RIIMQ-J对IBS诊断的敏感性也较高(89%)。RIIMQ-J在其他FBD患者中排除IBS的特异性令人满意(73%)。IBSSI-J显示出较高的内部一致性(0.69)和可重复性(组内相关系数,0.86,P < 0.001)。

结论

RIIMQ-J和IBSSI-J是用于检测和评估日本患者IBS状态严重程度的有效、可靠且合适的工具。

相似文献

1
Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index.罗马II型模块化问卷日语版及肠易激综合征严重程度指数的验证
J Gastroenterol. 2006 May;41(5):491-4. doi: 10.1007/s00535-006-1799-9.
2
Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J).肠易激综合征生活质量量表(IBS-QOL-J)日译本的翻译与验证。
Biopsychosoc Med. 2007 Mar 3;1:6. doi: 10.1186/1751-0759-1-6.
3
High prevalence of irritable bowel syndrome in medical outpatients in Japan.日本内科门诊患者中肠易激综合征的高患病率。
J Clin Gastroenterol. 2008 Oct;42(9):1010-6. doi: 10.1097/MCG.0b013e318150d006.
4
Validation of the Japanese version of comorbid conditions questionnaire (CCQ-J) and recent physical symptoms questionnaire (RPSQ-J).日本版共病状况问卷(CCQ-J)和近期身体症状问卷(RPSQ-J)的验证
Intern Med. 2011;50(5):375-80. doi: 10.2169/internalmedicine.50.4589. Epub 2011 Mar 1.
5
Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea.日本男性腹泻型肠易激综合征患者的肠易激综合征严重程度指数评估
Biopsychosoc Med. 2017 Mar 11;11:7. doi: 10.1186/s13030-017-0092-x. eCollection 2017.
6
Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients.肠易激综合征生活质量问卷对伊朗患者的语言验证
Acta Med Iran. 2011;49(6):390-5.
7
Validity and reliability of the Malay-language translation of the Rome III Diagnostic Questionnaire for irritable bowel syndrome.马来语翻译的罗马 III 诊断肠易激综合征问卷的有效性和可靠性。
J Gastroenterol Hepatol. 2012 Apr;27(4):746-50. doi: 10.1111/j.1440-1746.2011.06943.x.
8
Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.肠易激综合征的诊断:全科医生与罗马II标准之间的一致性较差。
Scand J Gastroenterol. 2004 May;39(5):448-53. doi: 10.1080/00365520310008782.
9
How individuals with the irritable bowel syndrome describe their own symptoms before formal diagnosis.肠易激综合征患者在正式诊断前如何描述自己的症状。
Ups J Med Sci. 2015;120(4):276-9. doi: 10.3109/03009734.2015.1040529.
10
Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia.日本版肠易激综合征和功能性消化不良罗马III诊断问卷的效度和信度
J Neurogastroenterol Motil. 2015 Oct 1;21(4):537-44. doi: 10.5056/jnm15016.

引用本文的文献

1
Effects of a Protease Inhibitor Camostat Mesilate on Gut Microbial Function in Patients with Irritable Bowel Syndrome: A Pilot Randomized Placebo-Controlled Study.蛋白酶抑制剂甲磺酸卡莫司他对肠易激综合征患者肠道微生物功能的影响:一项随机安慰剂对照的初步研究。
Digestion. 2024 Nov 25:1-12. doi: 10.1159/000542758.
2
Effect of Personalized Prebiotic and Probiotic Supplements on the Symptoms of Irritable Bowel Syndrome: An Open-Label, Single-Arm, Multicenter Clinical Trial.个性化益生元和益生菌补充剂对肠易激综合征症状的影响:一项开放标签、单臂、多中心临床试验。
Nutrients. 2024 Oct 1;16(19):3333. doi: 10.3390/nu16193333.
3
Association between disturbance of self-organization and irritable bowel syndrome in Japanese population using the international trauma questionnaire.

本文引用的文献

1
Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress.报告有肠道问题家族史的肠易激综合征患者和未咨询者有更严重的心理困扰。
Dig Dis Sci. 2004 Jun;49(6):1046-53. doi: 10.1023/b:ddas.0000034570.52305.10.
2
Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.肠易激综合征的诊断:全科医生与罗马II标准之间的一致性较差。
Scand J Gastroenterol. 2004 May;39(5):448-53. doi: 10.1080/00365520310008782.
3
Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study.
使用国际创伤问卷探讨日本人群中自我组织紊乱与肠易激综合征之间的关联。
Sci Rep. 2024 Aug 8;14(1):18412. doi: 10.1038/s41598-024-68196-y.
4
Factors Associated With the Prevalence of Irritable Bowel Syndrome: The Miyagi Part of the Tohoku Medical Megabank Project Community-based Cohort Study.与肠易激综合征患病率相关的因素:东北医学大数据库项目宫城县社区队列研究的一部分
J Neurogastroenterol Motil. 2024 Apr 30;30(2):208-219. doi: 10.5056/jnm23090.
5
Translation, validation, and first application of the Greek version of an irritable bowel syndrome severity scoring system.肠易激综合征严重程度评分系统希腊语版本的翻译、验证及首次应用。
Ann Gastroenterol. 2024 Mar-Apr;37(2):182-190. doi: 10.20524/aog.2024.0864. Epub 2024 Feb 10.
6
Psychosocial characteristics of workers with irritable bowel syndrome and its relationship with abdominal symptoms and work productivity.肠易激综合征患者的心理社会特征及其与腹部症状和工作生产力的关系。
J Occup Health. 2024 Jan 4;66(1). doi: 10.1093/joccuh/uiae012.
7
Progress Report of the Tohoku Medical Megabank Community-based Cohort Study: Study Profile of the Repeated Center-based Survey During Second Period in Miyagi Prefecture.东北医科药科大学医疗管理研究财团 基于社区的队列研究进度报告:宫城县第二次重复以中心为基础的调查研究概况。
J Epidemiol. 2024 Sep 5;34(9):434-443. doi: 10.2188/jea.JE20230241. Epub 2024 Jul 31.
8
Efficacy of an eHealth self-management program in reducing irritable bowel syndrome symptom severity: a randomized controlled trial.电子健康自我管理方案对降低肠易激综合征症状严重程度的疗效:一项随机对照试验。
Sci Rep. 2024 Jan 3;14(1):4. doi: 10.1038/s41598-023-50293-z.
9
A protease activity-based machine-learning approach as a complementary tool for conventional diagnosis of diarrhea-predominant irritable bowel syndrome.一种基于蛋白酶活性的机器学习方法,作为腹泻型肠易激综合征传统诊断的辅助工具。
Front Microbiol. 2023 Jul 7;14:1179534. doi: 10.3389/fmicb.2023.1179534. eCollection 2023.
10
Effect of G9-1 on the Intestinal Environment and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-like Symptoms in Patients with Quiescent Crohn's Disease: A Prospective Pilot Study.G9-1对静止期克罗恩病患者肠道环境及腹泻型肠易激综合征(IBS-D)样症状的影响:一项前瞻性初步研究
J Clin Med. 2023 May 9;12(10):3368. doi: 10.3390/jcm12103368.
细菌性肠胃炎会使人们易患功能性胃肠疾病吗?一项基于社区的前瞻性病例对照研究。
Am J Gastroenterol. 2003 Sep;98(9):1970-5. doi: 10.1111/j.1572-0241.2003.07664.x.
4
Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire.加拿大的功能性胃肠疾病:首次基于人群的使用罗马II标准的调查及问卷改进建议。
Dig Dis Sci. 2002 Jan;47(1):225-35. doi: 10.1023/a:1013208713670.
5
Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?依据不同诊断标准的肠易激综合征:新的罗马II标准对于研究和实践是否限制过严?
Am J Gastroenterol. 2000 Nov;95(11):3176-83. doi: 10.1111/j.1572-0241.2000.03197.x.
6
Functional bowel disorders and functional abdominal pain.功能性肠病和功能性腹痛。
Gut. 1999 Sep;45 Suppl 2(Suppl 2):II43-7. doi: 10.1136/gut.45.2008.ii43.
7
Irritable bowel syndrome: a technical review for practice guideline development.肠易激综合征:实践指南制定的技术综述
Gastroenterology. 1997 Jun;112(6):2120-37. doi: 10.1053/gast.1997.v112.agast972120.
8
The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.肠易激综合征严重程度评分系统:一种监测肠易激综合征及其进展的简单方法。
Aliment Pharmacol Ther. 1997 Apr;11(2):395-402. doi: 10.1046/j.1365-2036.1997.142318000.x.
9
Functional bowel disorders. A multicenter comparison of health status and development of illness severity index.
Dig Dis Sci. 1995 May;40(5):986-95. doi: 10.1007/BF02064187.
10
GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease.GSRS——一种用于肠易激综合征和消化性溃疡疾病患者胃肠道症状的临床评定量表。
Dig Dis Sci. 1988 Feb;33(2):129-34. doi: 10.1007/BF01535722.